are current employees of the Crucell Vaccine Institute. This article is a PNAS Direct Submission. This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1411755111/-/DCSupplemental.. importance in the design of next-generation vaccines and for prophylactic and therapeutic use. The two antibodies CR6261 and CR8020 have recently been shown to efficiently neutralize influenza A contamination by binding to and inhibiting the influenza A HA protein that is responsible for membrane fusion in the early actions of viral contamination. Here, we use single-particle fluorescence microscopy to correlate the number of antibodies or antibody fragments (Fab) bound to an individual virion with the capacity of the same virus particle to undergo membrane fusion. To this end, individual, infectious virus particles bound by fluorescently labeled antibodies/Fab are visualized as they fuse to a planar, supported lipid bilayer. The fluorescence intensity arising from the virus-bound antibodies/Fab is used to determine the number of molecules attached to viral HA while a fluorescent marker in the viral membrane is used to simultaneously obtain kinetic information around the fusion process. We experimentally determine that this stoichiometry required for fusion inhibition by both antibody and Fab leaves large numbers of unbound HA epitopes around the viral surface. Kinetic measurements of the fusion process reveal that those few particles capable of fusion at high antibody/Fab coverage display significantly slower hemifusion kinetics. Overall, our results support Carbamazepine a membrane fusion mechanism requiring the stochastic, Rabbit polyclonal to KATNB1 coordinated action of multiple HA trimers and a model of fusion inhibition by stem-binding antibodies through disruption of this coordinated action. Recently described antibodies capable of neutralizing a broad range of influenza viruses through recognition of highly conserved epitopes around the hemagglutinin protein (HA) have potential use as antiinfluenza therapeutics and for rational design of vaccines, HA-binding proteins, and small molecules (1C5). Such diverse applications require a detailed understanding of the infection mechanisms that are disrupted by antibody binding. An important parameter for in vitro antibody characterization is the binding stoichiometry, which relates the number of antibodies that must bind a virus in Carbamazepine order to achieve a functional output, such as viral neutralization (6, 7). Here, we use fluorescence microscopy to visualize individual virus particles and measure the stoichiometry of broadly neutralizing antibodies as they disrupt the fusogenic activity of the HA proteins. The homotrimeric HA transmembrane proteins Carbamazepine includes two disulfide-linked domains, HA2 and HA1 (8, 9), and displays considerable antigenic drift, having two phylogenetically specific groupsgroups 1 and 2with 18 subtypes (10). The HA1 mind site, distal through the viral envelope, consists of a binding site for sialic acidity moieties that binds virions to a focus on cell and facilitates their admittance into a mobile endosome via clathrin-mediated endocytosis. The HA2 stem site comprises the envelope-proximal ectodomain as well as the transmembrane site mostly. The reduced pH Carbamazepine lately endosomes causes the stem to unfold and embed its hydrophobic N-terminal area in to the endosomal membrane. Refolding from the proteins brings the viral and endosomal membranes close collectively and catalyzes their fusion (11, 12). Many biophysical studies reveal that multiple HA trimers must interact by coordinating their conformational adjustments for membrane fusion that occurs (13C16). Head-binding antibodies typically understand variable loop areas encircling the receptor site and display serotype-specific neutralization (1, 17, 18), even though some can neutralize a restricted group of viral serotypes (19C21). On the other hand, stem-binding antibodies understand an epitope area that is extremely conserved between influenza strains and still have a wide neutralization capability across many viral Carbamazepine subtypes (19, 22C26) and even across organizations (19, 27, 28). We proven that binding of HA from the broadly neutralizing lately, stem-binding antibodies CR6261 (group 1-particular) and CR8020 (group 2-particular) (22C24) leads to inhibition of HA-mediated viral membrane fusion (29). The power of antibodies to stop fusion confirms the availability of their membrane-proximal epitope on undamaged infections despite the thick packing of surface area protein (Fig. 1and = 0 is defined to lack of the fluorescein sign (dark green) upon appearance from the fusion-inducing pH 5.0 buffer. The proper time for you to hemifusion, 30 s because of this disease particle and it is noticed as the abrupt upsurge in R18 fluorescence (magenta). The virus-bound IgG/Fab fluorescence (light green) useful for stoichiometry measurements can be indicated from the package: 1 s following the pH drop and enclosing 3 s of.